Compare CWT & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWT | ALVO |
|---|---|---|
| Founded | 1926 | 2013 |
| Country | United States | Luxembourg |
| Employees | 1105 | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 1.5B |
| IPO Year | 1997 | N/A |
| Metric | CWT | ALVO |
|---|---|---|
| Price | $45.03 | $3.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $54.50 | $9.25 |
| AVG Volume (30 Days) | 360.2K | ★ 667.5K |
| Earning Date | 06-03-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.96% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.15 | N/A |
| Revenue | ★ $963,695,000.00 | N/A |
| Revenue This Year | $9.78 | $20.22 |
| Revenue Next Year | $3.92 | $37.22 |
| P/E Ratio | $21.02 | ★ $18.20 |
| Revenue Growth | ★ 6.41 | N/A |
| 52 Week Low | $41.29 | $3.45 |
| 52 Week High | $51.23 | $11.85 |
| Indicator | CWT | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 49.10 | 32.66 |
| Support Level | $45.04 | N/A |
| Resistance Level | $47.01 | $4.17 |
| Average True Range (ATR) | 1.14 | 0.19 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 51.09 | 24.22 |
California Water Service Group is a U.S. water and utilities holding company based in California. The company provides water utility and other related services in California, Washington, New Mexico, Hawaii and Texas through its wholly-owned subsidiaries. The bulk of the company's business consists of the production, purchase, storage, treatment, testing, distribution, and sale of water for domestic, industrial, public, and irrigation uses, and the provision of water for domestic and municipal fire protection services.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.